Serum galectin-3 and TGF-beta levels in patients with sarcoidosis
dc.authorid | Şenol Kobak / 0000-0001-8270-640X | en_US |
dc.authorscopusid | Şenol Kobak / 12782228700 | |
dc.authorwosid | Şenol Kobak / AAO-2482-2020 | |
dc.contributor.author | Kobak, Şenol | |
dc.contributor.author | Akyıldız, Muhittin | |
dc.contributor.author | Gökduman, Ayşe | |
dc.contributor.author | Atabay, Tennur | |
dc.contributor.author | Vural, Hüseyin | |
dc.date.accessioned | 2020-10-20T09:34:15Z | |
dc.date.available | 2020-10-20T09:34:15Z | |
dc.date.issued | 2020 | en_US |
dc.department | İstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | Introduction: Sarcoidosis is a chronic granulomatous disease that develops with non-caseified granuloma formation. Galectin-3 is a multifunctional protein operating in biological processes such as fibrosis, angiogenesis, and immune activation. Purpose: This study evaluates the levels of serum galectin-3 and TGF-beta in sarcoidosis patients to determine a possible correlation with clinical findings. Material and method: Forty-four biopsy-proven sarcoidosis patients followed in a single centre and 41 age and sex-matched healthy volunteers were included in the study. The levels of serum galectin-3 and TGF-beta were evaluated by ELISA method. Results: Among the 44 sarcoidosis patients, 13(29.5%) were male and 31(70.5%) were female. The average patient age was 47.4 and the average disease duration was 3.2 years. The level of serum galectin-3 was found to be the same as in the control group and had no significance statistically (p=.977). No correlation was determined between the level of serum galectin-3 and clinical and laboratory findings of sarcoidosis (p>.05). The level of serum TGF-beta was found to be higher in the sarcoidosis patients when compared to that of the control group (p=.005). While a correlation was found between serum TGF-beta and enthesitis, sacroiliitis, and arthralgia (p=.006, p=.034, p=.02), no correlation was determined on the other clinical and laboratory findings (p>.05). Conclusion: While the level of serum galectin-3 was determined to be normal in sarcoidosis patients, a high level of serum TGF-beta was found. These findings show that TGF-beta may play an important role in sarcoidosis pathogenesis and the formation of granuloma. | en_US |
dc.identifier.citation | Kobak, S., Akyildiz, M., Gokduman, A., Atabay, T., & Vural, H. (2020). Serum Galectin-3 and TGF-Beta Levels in Patients With Sarcoidosis. Reumatologia clinica, S1699-258X(20)30204-7. Advance online publication. https://doi.org/10.1016/j.reuma.2020.08.007 | en_US |
dc.identifier.doi | 10.1016/j.reuma.2020.08.007 | en_US |
dc.identifier.isbn | 1699-258X | |
dc.identifier.pmid | 33067139 | en_US |
dc.identifier.scopus | 2-s2.0-85092490520 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.reuma.2020.08.007 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/1147 | |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Kobak, Şenol | |
dc.language.iso | en | en_US |
dc.relation.ispartof | Reumatol Clin | en_US |
dc.relation.publicationcategory | Rapor | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Galectin-3 | en_US |
dc.subject | Galectina-3 | en_US |
dc.subject | Sarcoidosis | en_US |
dc.subject | TGF-beta | en_US |
dc.title | Serum galectin-3 and TGF-beta levels in patients with sarcoidosis | en_US |
dc.title.alternative | Niveles séricos de galectina-3 y TGF-beta en pacientes con sarcoidosis | en_US |
dc.type | Report | en_US |